ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 538.00
-12.00 (-2.18%)
Feb 5, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 63.55 billion as of February 5, 2026. Its market cap has decreased by -71.31% in one year.
Market Cap
63.55B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
538.00
Market Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 63.55B, an increase of 103.69%. That is a compound annual growth rate of 2.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 65.21B | -8.49% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 224.84B |
| Genexine | 216.48B |
| Macrogen | 202.41B |
| ENCell | 193.15B |
| GeneOne Life Science | 169.63B |
| IMB Dx | 129.94B |
| iNtRON Biotechnology | 116.79B |
| Oncocross | 107.31B |